Endovenous Ablation Devices Market Share, Trends, Business Strategy and Forecast to 2027

Albany NY, United States: Endovenous ablation devices are used to treat chronic venous insufficiency with varicose veins.

Albany NY, United States: Endovenous ablation devices are used to treat chronic venous insufficiency (CVI) with varicose veins. These type of devices are specially designed for minimally invasive procedures. Symptoms of varicose veins disease include large, swollen veins that often appear on legs and feet. This is happened when veins do not work properly, resulted blood does not flow effectively. In severe cases, varicose veins may rupture, or develop into varicose ulcers on the skin.

There are three type of endovenous ablation devices available in the market: endovenous laser ablation therapy (EVLT) devices, radiofrequency ablation (RFA) devices, and non-thermal non-tumescent (NTNT) devices. Endovenous laser ablation therapy is a method of treating varicose veins without surgery, in which, veins are heated by a laser. Radiofrequency ablation involves using an electrical current produced by a radio wave to heat up the nerve tissues in the affected area of a vein, thereby reducing the pain in that area.

Read Report Overview - https://www.transparencymarketresearch.com/endovenous-ablation-devices-market.html

Global Endovenous Ablation Devices Market: Competitive Landscape

Major players have adopted strategies such as partnerships, agreements, new product development, and collaborations to gain competitive advantage in the global endovenous ablation devices market.

  • In January 2019, Medtronic Plc acquired EPIX Therapeutics for expanding its ablation product portfolio
  • In January 2019, Venclose, Inc. partnered with Viant to deliver next-generation vein treatment solutions

Teleflex Incorporated

  • Founded in 1943, Teleflex Corporation is based in Wayne, New Jersey, U.S. The company has a diverse product portfolio with solutions in fields such as interventional access, vascular access, cardiology, anesthesia, surgical care, respiratory care, and emergency services. It provides Endovenous Ablation Procedure Packs for both endovenous laser ablation and radiofrequency ablation procedures.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=72309

Medtronic Plc

  • Established in 1949, Medtronic is based in Minneapolis, Minnesota, U.S. The company operates through four main business segments: Cardiac & Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. Medtronic operates in 160 countries across 480 locations globally, serving more than 65 million patients. It holds more than 45,000 patents in the medical technology industry. Medtronic offers products including Evident MW Ablation System, Cool-tip RF Ablation System, and Emprint SX Ablation Platform with Thermosphere Technology.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=72309

AngioDynamics

  • Founded in 1888, AngioDynamics is a minimally invasive medical devices provider for oncology, peripheral vascular disease, surgery, ablation, dialysis, and vascular access. The company has more than 1200 employees and it distributes its products in more than 50 countries across Europe, the U.S., Asia, and Latin America. The company has broad product portfolio that includes Solero Microwave Tissue Ablation System, NanoKnife System, StarBurst Radiofrequency Ablation System, and StarBurst MRI RFA Device for treatment of varicose veins.

Venclose, Inc.

  • Founded in 2014, Venclose, Inc. is a medical technology company engaged in developing next-generation solutions for treatment of chronic venous insufficiency. Venclose, Inc. provides a wide range of products for the treatment of chronic venous insufficiency, such as Venclose System, VENCLOSE RF Ablation Catheter, and VENCLOSE RF Generator.

Request for Analysis of COVID-19 Impact on Endovenous Ablation Devices Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=72309

Global Endovenous Ablation Devices Market: Dynamics

Increase in Prevalence of Chronic Venous Insufficiency and Associated Risk Factors to Boost Market

Increase in prevalence of chronic venous insufficiency is a major factor for expansion of the endovenous ablation devices market. According to a recent study, around 10% of adults suffer from chronic venous insufficiency. The prevalence of chronic venous insufficiency disease is high in developed countries as compared to developing countries. Untreated chronic venous insufficiency disease becomes life threatening. In addition, increasing prevalence of obesity, aging, smoking, and lack of physical activities are likely to cause chronic venous insufficiency disease. All these factors are expected to boost the market.

Pre Book Endovenous Ablation Devices Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=72309&ltype=S

Focus on Launch of Innovative Products to Boost Endovenous Ablation Devices Market

Manufacturers operating in the endovenous ablation devices market are strongly focusing on increasing investments in the research & development activities to design and develop new and innovative endovenous ablation devices. For instance, Medtronic plc has developed an innovative product, VenaSeal Closure System, which is the only non-thermal, non-tumescent, and non-sclerosant procedure that uses a proprietary medical adhesive delivered endovenously to close the vein.

More Trending Reports by Transparency Market Research:

Healthcare Additive Manufacturing Market: The global healthcare additive manufacturing market is growing due to the rising demand for personalized medical devices, such as implants, and the advent of sophisticated technology to manufacture a variety of products with complex and simple designs. Additive manufacturing is widely known as the next big thing after industrial revolution in the manufacturing sector.

Pharmaceutical Cleaning Validation Market: Numerous scientific advances have aided this new wave of pharmaceutical manufacturing revolution. The US Food and Drug Administration (FDA) is encouraging these developments by taking a more practical approach to regulation, which helps the industry speed up the development of therapies and life-saving medications.

Disposable Hospital Gowns Market: Disposable hospital gowns have grown in medical necessity for healthcare workers, considered as the one of the most important personal protective equipment, next only to gloves. A growing body of studies have underscored the benefits of hospital gowns in reducing the infection rate. Healthcare workers are routinely exposed to contact with blood, bodily fluids, secretions and excretions, and clothing of the patient.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/